ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,716,000 | -19.6% | 18,014 | -24.2% | 0.38% | -42.8% |
Q1 2020 | $2,135,000 | +55.0% | 23,759 | -24.9% | 0.66% | +77.3% |
Q4 2018 | $1,377,000 | -55.0% | 31,625 | -40.9% | 0.37% | -17.8% |
Q3 2018 | $3,063,000 | +45.4% | 53,517 | -5.2% | 0.46% | +62.5% |
Q3 2017 | $2,106,000 | +40.4% | 56,427 | +49.0% | 0.28% | +4.1% |
Q4 2013 | $1,500,000 | – | 37,871 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |